Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
STE STERIS plc
- Stocks
- Healthcare
- NYSE: STE
Price (delayed)
$241.24
Market cap
$23.73B
P/E Ratio
38.66
Dividend/share
$2.28
EPS
$6.24
Enterprise value
$25.76B
Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been
Highlights
The company's net income has surged by 63% YoY and by 31% QoQ
The company's EPS has surged by 63% YoY and by 32% QoQ
STERIS's quick ratio has decreased by 9% YoY
Key stats
What are the main financial stats of STE
Market
Valuations
Earnings
Shares outstanding
98.37M
Market cap
$23.73B
Enterprise value
$25.76B
Price to earnings (P/E)
38.66
Price to book (P/B)
3.59
Price to sales (P/S)
4.34
EV/EBIT
29.09
EV/EBITDA
18.92
EV/Sales
4.72
Revenue
$5.46B
Gross profit
$2.4B
Operating income
$866.64M
Net income
$614.64M
EBIT
$885.55M
EBITDA
$1.36B
Free cash flow
$787.19M
Per share
Balance sheet
Liquidity
EPS
$6.24
EPS diluted
$6.21
Free cash flow per share
$8.01
Book value per share
$67.21
Revenue per share
$55.57
TBVPS
$42.71
Total assets
$10.15B
Total liabilities
$3.53B
Debt
$2.2B
Equity
$6.6B
Working capital
$978.59M
Debt to equity
0.33
Current ratio
1.96
Quick ratio
1.19
Net debt/EBITDA
1.49
Margins
Efficiency
Dividend
EBITDA margin
24.9%
Gross margin
44%
Net margin
11.3%
Operating margin
15.9%
Return on assets
6.1%
Return on equity
9.5%
Return on invested capital
16.5%
Return on capital employed
9.7%
Return on sales
16.2%
Dividend yield
0.95%
DPS
$2.28
Payout ratio
36.5%
STE stock price
How has the STERIS stock price performed over time
Intraday
0.69%
1 week
2.12%
1 month
-0.72%
1 year
11.98%
YTD
17.36%
QTD
6.44%
Financial performance
How have STERIS's revenue and profit performed over time
Revenue
$5.46B
Gross profit
$2.4B
Operating income
$866.64M
Net income
$614.64M
Gross margin
44%
Net margin
11.3%
The company's net income has surged by 63% YoY and by 31% QoQ
STERIS's net margin has soared by 53% YoY and by 30% from the previous quarter
STE's gross profit is up by 8% year-on-year and by 2.5% since the previous quarter
The revenue has grown by 6% YoY
Price vs fundamentals
How does STE's price correlate with its fundamentals
Growth
What is STERIS's growth rate over time
Valuation
What is STERIS stock price valuation
P/E
38.66
P/B
3.59
P/S
4.34
EV/EBIT
29.09
EV/EBITDA
18.92
EV/Sales
4.72
The company's EPS has surged by 63% YoY and by 32% QoQ
STE's P/E is 43% below its 5-year quarterly average of 66.9 and 19% below its last 4 quarters average of 47.3
The company's equity rose by 4.8% YoY and by 2.9% QoQ
STE's P/B is 4.7% above its last 4 quarters average of 3.4
The P/S is 8% below the 5-year quarterly average of 4.7 but 5% above the last 4 quarters average of 4.1
The revenue has grown by 6% YoY
Efficiency
How efficient is STERIS business performance
STERIS's ROA has soared by 79% YoY and by 36% from the previous quarter
STERIS's ROIC has soared by 63% YoY and by 30% from the previous quarter
The ROE has soared by 58% YoY and by 30% from the previous quarter
The company's return on sales rose by 24% YoY and by 17% QoQ
Dividends
What is STE's dividend history
DPS
$2.28
Dividend yield
0.95%
Payout ratio
36.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did STERIS financials performed over time
The total assets is 187% more than the total liabilities
STERIS's current ratio has decreased by 36% YoY and by 8% QoQ
STE's total liabilities is down by 26% year-on-year
STERIS's debt is 67% less than its equity
STE's debt to equity is down by 39% year-on-year and by 8% since the previous quarter
STERIS's debt has decreased by 35% YoY and by 5% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.